PCVX
VaxcyteยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PCVX Profile
Vaxcyte, Inc.
A clinical-stage vaccine innovation company that engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases
825 Industrial Road, Suite 300, San Carlos, California 94070
--
Vaxcyte, Inc., was incorporated in Delaware on November 27, 2013. The company is a next-generation vaccine company that aims to improve global health by developing novel vaccines to prevent or treat some of the world's most common and deadly infectious diseases. Their cell-free protein synthesis platform enables them to design and produce protein carriers and antigens, which are key components of vaccines.
